Dalrada Health

The Importance of Cervical Cancer Awareness Month
January is a month of awareness and empowerment

Ensuring the year is off to a promising start, January is the perfect time to respect and support women around the world who are facing a Cervical cancer diagnosis or those who are being treated for the condition. January is also ideal for honoring the lives lost to this deadly, yet preventable disease.

Not long ago, the Cervical cancer mortality rate was ranked the third-highest among cancers in women. Today, cervical cancer is ranked fourth. And while that may seem like a small accomplishment, there’s still reason to celebrate.

Dalrada Health firmly believes that eradicating Cervical cancer is possible. It starts with awareness, education, prevention, early detection, and effective treatment – all of which are vital to the cause of reducing global rates of Cervical cancer.

In November of 2020, the World Health Organization (WHO) announced its plan for all countries to accelerate the end of Cervical cancer. By the year 2030, the goal is to affect the population with the following:

  • HPV (human papillomavirus) vaccinations among 90% of girls by the age of 15 to prevent infections that can cause cervical cancer
  • 70% screening coverage of women by the age of 35 and again by 45
  • Treating 90% of women identified with Cervical cancer

Sadly, developing countries lack medical resources compared to more advanced and developed nations. This deficiency translates to shouldering the heavy burden of Cervical cancer. Geographical areas significantly affected by cervical cancer include sub-Saharan Africa, Melanesia, South America, and South-Eastern Asia. Within these locations, 23 countries report Cervical cancer as the most commonly-diagnosed form of cancer among women, and 36 countries report Cervical cancer as the leading cause of cancer deaths in women.

Unavailable in developing nations are the traditional cytology screening tests (Pap smear), laboratories, and specialized healthcare resources used by other countries to reduce cervical cancer instances. However, optimism is growing as medical and technological advances are narrowing the disparity between developed and undeveloped nations.

As global awareness of Cervical cancer increases, educational resources will become more readily available, and aggressive prevention methods will be adopted – including effective and accessible Cervical cancer screenings and ultimately, treatment options will evolve to reach all women.

Dalrada Health is positively impacting women’s health and is committed to giving the world more reasons to celebrate reductions in Cervical cancer instances – and not just during the month of January.

Using cerVIA™ standardized visual inspection with acetic acid (VIA) tests, Dalrada Health just completed its second round of Cervical cancer screening clinical trials in India, one of the most heavily-impacted nations in the world. In the first round of clinical trials, cerVIA™ surpassed traditional cytology screening results and provided results at the time of the procedure. cerVIA™ validates the results from other cervical cancer screening tests, including Pap smears.

As an impactful diagnostic solution for women, Dalrada Health makes cerVIA™ Cervical cancer screening kits affordable and available to countries lacking the technology and personnel to support cytology tests.

With cerVIA™, practitioners and patients receive precious time – and that’s even more cause to celebrate.

Join Dalrada Health in its commitment to the vision of “a world without Cervical cancer” not only during January, but throughout the year.

divider

DALRADA
LATEST NEWS

The Importance of Cervical Cancer Awareness Month
January is a month of awareness and empowerment

Ensuring the year is off to a promising start, January is the perfect time to respect and support women around the world who are facing a Cervical cancer diagnosis or those who are being treated for the condition. January is also ideal for honoring the lives lost to this deadly, yet preventable disease.

Not long ago, the Cervical cancer mortality rate was ranked the third-highest among cancers in women. Today, cervical cancer is ranked fourth. And while that may seem like a small accomplishment, there’s still reason to celebrate.

Dalrada Health firmly believes that eradicating Cervical cancer is possible. It starts with awareness, education, prevention, early detection, and effective treatment – all of which are vital to the cause of reducing global rates of Cervical cancer.

In November of 2020, the World Health Organization (WHO) announced its plan for all countries to accelerate the end of Cervical cancer. By the year 2030, the goal is to affect the population with the following:

  • HPV (human papillomavirus) vaccinations among 90% of girls by the age of 15 to prevent infections that can cause cervical cancer
  • 70% screening coverage of women by the age of 35 and again by 45
  • Treating 90% of women identified with Cervical cancer

Sadly, developing countries lack medical resources compared to more advanced and developed nations. This deficiency translates to shouldering the heavy burden of Cervical cancer. Geographical areas significantly affected by cervical cancer include sub-Saharan Africa, Melanesia, South America, and South-Eastern Asia. Within these locations, 23 countries report Cervical cancer as the most commonly-diagnosed form of cancer among women, and 36 countries report Cervical cancer as the leading cause of cancer deaths in women.

Unavailable in developing nations are the traditional cytology screening tests (Pap smear), laboratories, and specialized healthcare resources used by other countries to reduce cervical cancer instances. However, optimism is growing as medical and technological advances are narrowing the disparity between developed and undeveloped nations.

As global awareness of Cervical cancer increases, educational resources will become more readily available, and aggressive prevention methods will be adopted – including effective and accessible Cervical cancer screenings and ultimately, treatment options will evolve to reach all women.

Dalrada Health is positively impacting women’s health and is committed to giving the world more reasons to celebrate reductions in Cervical cancer instances – and not just during the month of January.

Using cerVIA™ standardized visual inspection with acetic acid (VIA) tests, Dalrada Health just completed its second round of Cervical cancer screening clinical trials in India, one of the most heavily-impacted nations in the world. In the first round of clinical trials, cerVIA™ surpassed traditional cytology screening results and provided results at the time of the procedure. cerVIA™ validates the results from other cervical cancer screening tests, including Pap smears.

As an impactful diagnostic solution for women, Dalrada Health makes cerVIA™ Cervical cancer screening kits affordable and available to countries lacking the technology and personnel to support cytology tests.

With cerVIA™, practitioners and patients receive precious time – and that’s even more cause to celebrate.

Join Dalrada Health in its commitment to the vision of “a world without Cervical cancer” not only during January, but throughout the year.

divider

DALRADA
LATEST NEWS

Skip to content